Back to catalog
Hair-loss research
KX-826
30mL, 5mg/mL
Anti-androgen research compound formulated as a liquid solution.
Overview
KX-826 (Pyrilutamide) is an androgen receptor antagonist currently researched for its topical application in hair growth studies. It is designed to minimize systemic exposure while targeting local androgen receptor activity.
Mechanism of action
It functions as a high-affinity competitive antagonist of the androgen receptor.
Dosage & concentration
5 mg/mL concentration. 30 mL bottle contains 150 mg total.
Storage & handling
Keep in a cool, dry place protected from light.
Research & studies
- What's New in Therapy for Male Androgenetic Alopecia?Am J Clin Dermatol · 2023
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia.Front Pharmacol · 2026
- Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia.J Med Chem · 2026